Announcement on the expiry of members
of the 4th term Remuneration Committee.
Date of events
2022/06/17
To which item it meets
paragraph 6
Statement
1.Date of occurrence of the change:2022/06/17
2.Name of the functional committees:Remuneration Committee.
3.Name of the previous position holder:
Chan Tzu-Sheng
Chang Wu-I
Shih Mei-Hui
4.Resume of the previous position holder:
Chan Tzu-Sheng:Independent director of the Company.
Chang Wu-I:Independent director of the Company.
Shih Mei-Hui:Accountant in Yide United Certified Public Accountants.
5.Name of the new position holder:Not appointment yet.
6.Resume of the new position holder:Not appointment yet.
7.Circumstances of change (Please enter "resignation", "dismissal",
"term expired", "death" or "new appointment"):Term expired.
8.Reason for the change:Term expired.
9.Original term (from __________ to __________):From 2019/07/03 to 2022/06/17
10.Effective date of the new member:Not applicable.
11.Any other matters that need to be specified:The Board of Directors
will appoint the members of the Remuneration Committee.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Excelsior Medical Co. Ltd. published this content on 17 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 June 2022 10:22:03 UTC.
EXCELSIOR MEDICAL CO., LTD. is a Taiwan-based company principally engaged in the distribution, maintenance and leasing of medical equipment and supplies. The Companyâs principal products include artificial kidneys, hemodialysis blood tubing sets and epidural needles, dialysis liquid medicines and powder medicines, dialysis machines, human erythropoietin, surgery consumable materials, blood bags, plasma replacement machines and beauty medical equipment, among others. The Company is also involved in the production and sales of self-owned soybean milk machines, as well as household air fresheners under the brand name of Coway. The Company mainly operates its businesses in domestic market and overseas markets.